Sensitive ASX Announcement

Receives Medical Ethics Approval to Begin Phase III Trial

Published: 31/01/07, 10:00am (AEST)3 pages
Clinuvel Pharmaceuticals
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only